Lenacapavir

Anti-HIV drug Lenacapavir shows 100% efficacy, no safety concerns in women: Study – Firstpost

by
Anti-HIV drug Lenacapavir shows 100% efficacy, no safety concerns in women: Study – Firstpost

Lenacapavir, injectable twice a year, is developed by the US-based biopharmaceutical company Gilead Sciences, Inc. as a pre-exposure prophylaxis (PrEP) drug. These drugs prevent the spread of infection in people not yet exposed to the disease-causing agent read more An HIV-preventive drug showed 100 per cent efficacy and ”no safety concerns” in women, according to … Read more

HIV: New ‘vaccine-like’ HIV drug could cost just $40: researchers

by
HIV: New ‘vaccine-like’ HIV drug could cost just : researchers

PARIS: A new ‘vaccine-like’ HIV drug that currently costs over $40,000 per person a year could be made for as little as $40, researchers estimated on Tuesday.The antiretroviral drug Lenacapavir, developed by US pharmaceutical giant Gilead, has been hailed as a potential game-changer in the fight against HIV.Early trials have found the treatment is 100 … Read more